Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
4.

A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.

Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.

Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.

5.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
6.

[Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].

Roick C, Ahrens B, Becker T.

Psychiatr Prax. 2001 Jul;28 Suppl 1:S32-40. Review. German.

PMID:
11533905
7.

Treatments for late-life bipolar disorder.

Aziz R, Lorberg B, Tampi RR.

Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. Review.

PMID:
17296540
8.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
9.

Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?

Haymond J, Ensom MH.

Ther Drug Monit. 2010 Feb;32(1):19-29. doi: 10.1097/FTD.0b013e3181c13a30. Review.

PMID:
19901867
10.

A review of anticonvulsants in treating agitated demented elderly patients.

Grossman F.

Pharmacotherapy. 1998 May-Jun;18(3):600-6. Review.

PMID:
9620110
11.

Cost considerations in oral antibiotic therapy.

Ballow CH.

Adv Ther. 1995 Jul-Aug;12(4):199-206. Review.

PMID:
10155348
12.

Economic aspects of antibacterial adverse effects.

Beringer PM, Wong-Beringer A, Rho JP.

Pharmacoeconomics. 1998 Jan;13(1 Pt 1):35-49. Review.

PMID:
10175984
13.

Alopecia and mood stabilizer therapy.

McKinney PA, Finkenbine RD, DeVane CL.

Ann Clin Psychiatry. 1996 Sep;8(3):183-5. Review.

PMID:
8899137
14.

Costing intensive care services: a review of study methods, results and limitations.

Elliott D.

Aust Crit Care. 1997 Jun;10(2):55-63. Review.

PMID:
9250035
15.

IV drug use, dementia, and nursing home care for PWAs (persons with AIDS).

Swan JH, Benjamin AE.

J Health Soc Policy. 1993;4(3):79-91. Review.

PMID:
10125467
16.

Pharmacoeconomic issues in the treatment of depression.

Saklad SR.

Pharmacotherapy. 1995 Nov-Dec;15(6 Pt 2):76S-83S. Review.

PMID:
8587854
17.

Major costs associated with pressure sores.

Javitz HS, Ward MM, Martens L.

J Wound Care. 1998 Jun;7(6):286-90. Review.

PMID:
9697461
18.

Lithium and kidney, 60 years later.

Raja M.

Curr Drug Saf. 2011 Nov 1;6(5):291-303. Review.

PMID:
22424536
19.

[Economic impact of adverse drug effects. Some reflections].

Spreux A, Chichmanian RM, Castot A.

Therapie. 1992 Sep-Oct;47(5):385-8. Review. French.

PMID:
1299976
20.

Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature.

Mahmoud F, Tampi RR.

Am J Geriatr Pharmacother. 2011 Dec;9(6):405-12. doi: 10.1016/j.amjopharm.2011.09.002. Epub 2011 Oct 10. Review.

PMID:
21993183
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk